- Teladoc is a growth company that is worth a look.
- Teladoc recently reported full-year 2017 results and provided 2018 guidance that supported the bull case for the company.
- I am long Teladoc and I plan to add shares on pullbacks.
Teladoc ($TDOC) has a goal to change the healthcare field as we know it. A little dramatic, yes, but the company's telehealth platform (and other related services) allow for patients to connect with their doctors without going in for a typical appointment. The platform connects doctors and patients through mobile devices, internet, video and the phone. And if you look out over the next few decades, I believe that this type of service will continue to experience tremendous growth.
It is important to also note that the market has already taken notice, as shown by the fact that TDOC shares are up almost 70% over the last year.
More recently, however, the stock has been under pressure and is now trading in the lower $40 per share range. In my opinion, investors with a time horizon longer than three-to-five years should treat any pullbacks as long-term buying opportunities.
Read more here.